NL-OMON30515招募中4 期
Prospective follow-up study of adalimumab treatment in ankylosing spondylitis: efficacy with focus on uveitis - Adalimumab, uveitis and ankylosing spondylitis
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Ankylosing spondylitis according to the modified New York criteria, who will start with adalimumab.
排除标准
- •1. Persistent chronic or active infections
- •2. History of amlignancy
- •3. Immuno-compromised conditions.
- •4. History of central nervous system (CNS) demyelinating disease.
- •5. Female subject who is pregnant or breast-feeding or considering becoming pregnant during the study.
- •6. Known history of allergic reaction or significant hypersensitivity to the constituents of adalimumab.
研究者
相似试验
尚未招募
2 期
The effect of Adalimumab in the treatment of patients with chronic schizophreniaSchizophrenia.SchizophreniaIRCT20090117001556N126Tehran University of Medical Sciences50
招募中
不适用
Efficacy of maintenance therapy with adalimumab in ulcerative colitis achieving remission with tacrolimusulcerative colitisJPRN-UMIN000015912Osaka Medical College50
已完成
不适用
Prospective study on the effects of adalimumab treatment in patients with rheumatoid arthritisMusculoskeletal DiseasesArthropathiesRheumatoid arthritisISRCTN68762628Academic Medical Center (AMC) (The Netherlands)50
已完成
2 期
Phase ll Study of Postoperative Adalimumab Maintenance Therapy for Crohn's Disease Recurrences diseaseCrohn's diseaseJPRN-UMIN000007514agoya University Gradeate School of Medicine Department of Gastroenterology25
已完成
不适用
The Study for Efficacy and Safety of Adalimumab for Crohn's Disease with Loss of Response to InfliximabCrohn's Disease patient as following 1)or 2) 1)the patient who treated with IFX infusion of interval every 4-6 weeks. 2)the patient who could not keep to treat with IFX due to side effect or ineffectiveness.JPRN-UMIN000005761Kenji Watanabe50